
PET Imaging for Head and Neck Cancers.
Head and neck cancers are commonly encountered cancers in clinical practice in the United States. Fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT has been clinically applied in staging, occult primary tumor detection, treatment planning, response assessment, follow-up, recurrent disease detection, and prognosis prediction in these patients. Alternative PET tracers remain investigational and can provide additional valuable information such as radioresistant tumor hypoxia. The recent introduction of 18F-FDG PET/MR imaging has provided the advantage of combining the superior soft tissue resolution of MR imaging with the functional information provided by 18F-FDG PET. This article is a concise review of recent advances in PET imaging in head and neck cancer.
Duke Scholars
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Humans
- Head and Neck Neoplasms
- Fluorodeoxyglucose F18
- 3203 Dentistry
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation

Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Humans
- Head and Neck Neoplasms
- Fluorodeoxyglucose F18
- 3203 Dentistry
- 3202 Clinical sciences
- 1103 Clinical Sciences